A new analysis by researchers at the Lewis Katz School of Medicine at Temple University shows that endovascular therapy currently is the safest and most effective treatment for superior vena cava syndrome (SVCS). The review by Riyaz Bashir, MD, FACC, RVT, Professor of Medicine at the Katz School of Medicine and Director of Vascular and Endovascular Medicine at Temple University Hospital, and colleagues was published online in the journal EClinicalMedicine. Outlets including Bioengineer.org, Scienmag and News-Medical.net highlighted the news.